Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization

Xin Han's Biography



Xin Han, Research Associate, Houston Methodist Research Institute

Dr. Xin Han is a Research Associate in Department of Nanomedicine at Houston Methodist Research Institute. Dr. Han received his Ph.D. from Zhongshan University, Guangzhou, China and joined Houston Methodist Research Institute as a postdoctoral fellow. His research focus is translational medicine in microfluidics. He has senior-authored research papers published in leading journals including Science Advances, PNAS, JACS, AngewChemie, Genes &Development, Cell Reports and others.

Xin Han Image

Microfluidic Biotechnology Enables CRISPR-Cas9 System for Gene Therapy and Cancer Biomarker Discovery

Wednesday, 4 October 2017 at 09:00

Add to Calendar ▼2017-10-04 09:00:002017-10-04 10:00:00Europe/LondonMicrofluidic Biotechnology Enables CRISPR-Cas9 System for Gene Therapy and Cancer Biomarker DiscoverySELECTBIOenquiries@selectbiosciences.com

The CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) nuclease system represents an efficient tool for genome editing and gene function analysis. Integrated microfluidic chips have been well designed with micro and nanostructures to rapidly distinguish cell morphology and dynamics, which are uniquely advantageous in improving efficiency of CRISPR based delivery and screening. Here we combined the two unique technologies to facilitate cancer biomarker discovery and gene therapy.


Add to Calendar ▼2017-10-02 00:00:002017-10-04 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and CommercializationSELECTBIOenquiries@selectbiosciences.com